当前位置: 首页 > 期刊 > 《中国实用医药》 > 2019年第11期
编号:13383936
颅内血肿微创清除术联合亚低温治疗重症高血压脑出血临床效果观察(1)
http://www.100md.com 2019年4月15日 《中国实用医药》 2019年第11期
     【摘要】 目的 觀察对重症高血压脑出血患者行颅内血肿微创清除术联合亚低温治疗的临床效果。方法 110例重症高血压脑出血患者, 随机分为对照组和研究组, 每组55例。对照组患者行颅内血肿微创清除术治疗, 研究组患者行颅内血肿微创清除术联合亚低温治疗。观察比较两组患者的临床效果及治疗前后日常生活活动能力评定量表(BI)指数、格拉斯哥昏迷评分法(GCS)评分、美国国立卫生研究院卒中量表(NIHSS)评分。结果 经治疗后, 研究组患者总有效率为90.91%, 明显高于对照组的70.91%, 差异有统计学意义(χ2=7.122, P=0.008<0.05)。治疗前, 两组患者的BI指数、GCS评分、NIHSS评分比较差异均无统计学意义(P>0.05)。治疗后, 研究组患者的NIHSS评分(6.27±2.11)分明显低于对照组的(12.97±3.70)分, BI指数(86.95±6.15)分及GCS评分(9.36±2.19)分均明显高于对照组的(76.66±5.54)、(7.34±2.10)分, 差异均有统计学意义(P<0.05)。结论 对重症高血压脑出血患者行颅内血肿微创清除术联合亚低温治疗可以取得确切疗效, 同时具有较高的安全性, 临床价值显著, 值得推广。

    【关键词】 颅内血肿微创清除术;亚低温;重症高血压脑出血;临床效果

    DOI:10.14163/j.cnki.11-5547/r.2019.11.001

    【Abstract】 Objective To observe the clinical effect of minimally invasive intracranial hematoma drainage combined with mild hypothermia in the treatment of severe hypertensive intracerebral hemorrhage. Methods A total of 110 patients with severe hypertensive intracerebral hemorrhage were randomly divided into control group and research group, with 55 cases in each group. The control group was treated with minimally invasive intracranial hematoma drainage, and the research group was treated with minimally invasive intracranial hematoma drainage combined with mild hypothermia. Observation and comparison were made on clinical effect, Barthel index (BI), Glasgow coma score (GCS), National Institutes of Health Stroke scale (NIHSS) Score before and after treatment in two groups. Results After treatment, the research group had obviously higher total effective rate as 90.91% than 70.91% in the control group, and the difference was statistically significant (χ2=7.122, P=0.008<0.05). Before treatment, both groups had no statistically significant difference in BI index, GCS score and NIHSS score (P>0.05). After treatment, the research group had obviously lower NIHSS score as (6.27±2.11) points than (12.97±3.70) points in the control group, and obviously higher BI index as (86.95±6.15) and GCS score (9.36±2.19) points than (76.66±5.54) and (7.34±2.10) points in the control group. Their difference was statistically significant (P<0.05). Conclusion Minimally invasive intracranial hematoma drainage combined with mild hypothermia shows affirmative efficacy in the treatment of severe hypertensive intracerebral hemorrhage, and it has high safety and remarkable clinical value. It is worthy of promotion.

    【Key words】 Minimally invasive intracranial hematoma drainage; Mild hypothermia; Severe hypertensive intracerebral hemorrhage; Clinical effect, 百拇医药(薛立果 徐延德 宋家栋 孙玺弘 王锡山)
1 2下一页